PURPOSE: To evaluate the efficacy of intrastromal ring segment (Intacs, Addition Technology, Inc.) implantation and analyze outcomes according to different keratoconus stages. SETTING: Kudret Eye Hospital, Ankara, Turkey. METHOD: In this retrospective noncomparative case series, 306 keratoconic eyes of 255 patients who had Intacs segment implantation were reviewed. Patients were grouped according to the Amsler-Krumeich keratoconus classification (stage II, 155 eyes; stage III, 83 eyes; stage IV, 68 eyes). The uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), central corneal curvature, spherical and cylindrical manifest refractions, and central corneal thickness were analyzed and compared according to keratoconus stage. RESULTS: At a mean follow-up of 10.39 months +/- 5.04 (SD), the BCVA improved in 71.6% of eyes and the UCVA improved in 75.7% of eyes. The mean keratometry (K) decreased from 50.7 diopters (D) to 47.9 D (P<.05); the mean manifest spherical refraction, from -6.04 D to -3.09 D (P<.05); and the mean manifest cylindrical refraction, from -4.11 D to -3.82 D (P>.05). The changes in BCVA and manifest spherical and cylindrical refractions were not statistically different between the different keratoconus stages (P >.05). There was less change in UCVA and more improvement in the mean K value after Intacs treatment in stage IV than in the other stages (P<.05, analysis of variance). CONCLUSIONS: Intacs treatment with a femtosecond laser was effective for management of keratoconus of all stages. Improvement in UCVA may be less in severe keratoconus than in moderate keratoconus.
PURPOSE: To evaluate the efficacy of intrastromal ring segment (Intacs, Addition Technology, Inc.) implantation and analyze outcomes according to different keratoconus stages. SETTING: Kudret Eye Hospital, Ankara, Turkey. METHOD: In this retrospective noncomparative case series, 306 keratoconic eyes of 255 patients who had Intacs segment implantation were reviewed. Patients were grouped according to the Amsler-Krumeich keratoconus classification (stage II, 155 eyes; stage III, 83 eyes; stage IV, 68 eyes). The uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), central corneal curvature, spherical and cylindrical manifest refractions, and central corneal thickness were analyzed and compared according to keratoconus stage. RESULTS: At a mean follow-up of 10.39 months +/- 5.04 (SD), the BCVA improved in 71.6% of eyes and the UCVA improved in 75.7% of eyes. The mean keratometry (K) decreased from 50.7 diopters (D) to 47.9 D (P<.05); the mean manifest spherical refraction, from -6.04 D to -3.09 D (P<.05); and the mean manifest cylindrical refraction, from -4.11 D to -3.82 D (P>.05). The changes in BCVA and manifest spherical and cylindrical refractions were not statistically different between the different keratoconus stages (P >.05). There was less change in UCVA and more improvement in the mean K value after Intacs treatment in stage IV than in the other stages (P<.05, analysis of variance). CONCLUSIONS: Intacs treatment with a femtosecond laser was effective for management of keratoconus of all stages. Improvement in UCVA may be less in severe keratoconus than in moderate keratoconus.
Authors: Ha Ae Bae; Richard A D Mills; Richard G Lindsay; Tony Phillips; Douglas J Coster; Paul Mitchell; Jie Jin Wang; Jamie E Craig; Kathryn P Burdon Journal: Invest Ophthalmol Vis Sci Date: 2013-07-30 Impact factor: 4.799
Authors: José F Alfonso; Carlos Lisa; Luis Fernández-Vega; David Madrid-Costa; Robert Montés-Micó Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-08-13 Impact factor: 3.117